Skip to content

KLRS KLRS Interest coverage

Interest coverage at other companies

Amgen logo
AmgenAMGN
3.9×+1.5×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
75.6×-4.5×
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
-7,376.8×
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-25.8×+35.4×
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
-42,382.4×-296,817×
Regenxbio logo
RegenxbioRGNX
-5.7×-1.3×

Other financials

Income statement

See full
Operating income-$11.8M-14.3%
Net income-$10.9M-6.5%
EPS (diluted)-$0.46+81.7%

Balance sheet

See full
Cash & equivalents$34.4M-65.9%
Total debt$1.4M
Total equity$68.6M+7.3%
Total assets$109.8M+6.5%

Cash flow

See full
Operating cash flow-$11.6M-55.6%
CapEx$17.0K
Free cash flow-$7.1M

Valuation

See full
Market cap$96.83M+136%
Enterprise value$63.82M

Returns & leverage

See full
Return on equity-66.6%
Debt / equity
Current ratio12.2×-2.1×

Where this comes from

Calculated from KLRS’s reported figures.

Based on trailing twelve months.

The official record: KLRS’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KLRS's interest coverage?
KLRS (KLRS) reported interest coverage of -32× in Q4 2025.
How has KLRS's interest coverage changed year-over-year?
KLRS's interest coverage decreased by 67.0% year-over-year, from -19.2× to -32×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.